Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

CD84 is markedly up-regulated in Kawasaki disease arteriopathy.

Reindel R, Bischof J, Kim KY, Orenstein JM, Soares MB, Baker SC, Shulman ST, Perlman EJ, Lingen MW, Pink AJ, Trevenen C, Rowley AH.

Clin Exp Immunol. 2014 Jul;177(1):203-11. doi: 10.1111/cei.12327.

2.
3.

Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.

Nomura I, Abe J, Noma S, Saito H, Gao B, Wheeler G, Leung DY.

Pediatr Res. 2005 Jan;57(1):49-55. Epub 2004 Nov 5.

PMID:
15531734
4.

[The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease].

Wang GB, Li CR, Zu Y, Yuan XW.

Zhonghua Er Ke Za Zhi. 2006 May;44(5):333-6. Chinese.

PMID:
16780707
5.

Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.

Ebata R, Abe J, Yasukawa K, Hamada H, Higashi K, Suwazono Y, Saito H, Terai M, Kohno Y.

Circ J. 2011;75(6):1455-62. Epub 2011 Apr 12.

6.

Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.

Fury W, Tremoulet AH, Watson VE, Best BM, Shimizu C, Hamilton J, Kanegaye JT, Wei Y, Kao C, Mellis S, Lin C, Burns JC.

Hum Immunol. 2010 Sep;71(9):865-73. doi: 10.1016/j.humimm.2010.06.008. Epub 2010 Jun 20.

7.

Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium.

Freeman AF, Crawford SE, Cornwall ML, Garcia FL, Shulman ST, Rowley AH.

Pediatr Cardiol. 2005 Sep-Oct;26(5):578-84.

PMID:
16132289
8.

Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Ikeda K, Yamaguchi K, Tanaka T, Mizuno Y, Hijikata A, Ohara O, Takada H, Kusuhara K, Hara T.

Clin Exp Immunol. 2010 May;160(2):246-55. doi: 10.1111/j.1365-2249.2009.04073.x. Epub 2009 Dec 15.

10.

Oligoclonal IgA response in the vascular wall in acute Kawasaki disease.

Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC.

J Immunol. 2001 Jan 15;166(2):1334-43.

11.

Gene-expression patterns reveal underlying biological processes in Kawasaki disease.

Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, Brown PO, Burns JC, Relman DA.

Genome Biol. 2007;8(12):R261.

12.

[Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].

Yang SW, Wang DW, Li J, Qin YM, Wang FM, Cao LM, Zhang LF, Hu Z.

Zhonghua Er Ke Za Zhi. 2005 Aug;43(8):612-5. Chinese.

PMID:
16191276
13.

Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.

Hofmann S, Braun A, Pozgaj R, Morowski M, Vögtle T, Nieswandt B.

PLoS One. 2014 Dec 31;9(12):e115306. doi: 10.1371/journal.pone.0115306. eCollection 2014.

14.

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.

Ge X, Li CR, Yang J, Wang GB.

Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022.

15.

Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).

Romero X, Benítez D, March S, Vilella R, Miralpeix M, Engel P.

Tissue Antigens. 2004 Aug;64(2):132-44.

PMID:
15245368
16.

Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease.

Miura M, Garcia FL, Crawford SE, Rowley AH.

Pediatr Infect Dis J. 2004 Oct;23(10):931-6.

PMID:
15602193
17.

Transient thrombocytopenia with large platelets in Kawasaki disease.

Asano T, Sudoh M, Watanabe M, Fujino O.

Pediatr Hematol Oncol. 2007 Oct-Nov;24(7):551-4.

PMID:
17786792
18.

Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling.

Nanda N, Andre P, Bao M, Clauser K, Deguzman F, Howie D, Conley PB, Terhorst C, Phillips DR.

Blood. 2005 Nov 1;106(9):3028-34. Epub 2005 Jul 21.

19.

Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease.

Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, Takagi J, Akagi T, Maeno Y, Kawano T, et al.

Circulation. 1994 Jan;89(1):258-65.

PMID:
8281655
20.

Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease.

Yamamura K, Ihara K, Ikeda K, Nagata H, Mizuno Y, Hara T.

Int J Immunogenet. 2012 Apr;39(2):119-25. doi: 10.1111/j.1744-313X.2011.01065.x. Epub 2011 Nov 25.

PMID:
22117627

Supplemental Content

Support Center